NCT01214590

Preliminary Assessment of the Efficacy of the VascuActive™ Device on Diabetic Peripheral Neuropathy

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 15 (estimated)
• Sponsor: VascuActive LTD · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess the safety and the preliminary efficacy of treatment by the VascuActive device on peripheral diabetic neuropathy, and to correlate this effect with physiologic changes. Patients will undergo a 4-week period of home treatment by the VascuActive device, and will be monitored during this period and during a two-month follow-up period for the efficacy of the device in reducing neuropathic pain, sensation impairment and other signs and symptoms.

Conditions

• Diabetic Neuropathy, Painful

Interventions

Type	Name	Description
DEVICE	VascuActive device	self treatment by the patient, for 4 weeks, 3 sessions per day, approximately 30 minutes per session

Timeline

• Start date: 2011-03-01
• Primary completion: 2012-02-01
• First posted: 2010-10-05
• Last updated: 2011-04-13

Locations

1 site across 1 country: Israel